Results 41 to 50 of about 3,193,961 (325)

ANTIFUNGAL RESISTANCE: A GROWING CONCERN

open access: yesActa Biológica Colombiana, 2023
Globally, the increasing number of drug-resistant human pathogens represents a major threat to public health. Among these pathogens, fungi that have acquired resistance to the already scarce arsenal of antifungals are of particular significance, as they ...
C. Firacative
semanticscholar   +1 more source

Resistance to antifungals that target CYP51 [PDF]

open access: yesJournal of Chemical Biology, 2014
Fungal diseases are an increasing global burden. Fungi are now recognised to kill more people annually than malaria, whilst in agriculture, fungi threaten crop yields and food security. Azole resistance, mediated by several mechanisms including point mutations in the target enzyme (CYP51), is increasing through selection pressure as a result of ...
Josie Parker   +5 more
openaire   +5 more sources

Emerging threats in antifungal-resistant fungal pathogens

open access: yesFrontiers in Medicine, 2016
The use of antifungal drugs in the therapy of fungal diseases can lead to the development of antifungal resistance. Resistance has been described for virtually all antifungal agents in diverse pathogens including Candida and Aspergilli species.
Dominique eSanglard
doaj   +1 more source

Mechanisms of Antifungal Drug Resistance [PDF]

open access: yesCold Spring Harbor Perspectives in Medicine, 2014
Antifungal therapy is a central component of patient management for acute and chronic mycoses. Yet, treatment choices are restricted because of the sparse number of antifungal drug classes. Clinical management of fungal diseases is further compromised by the emergence of antifungal drug resistance, which eliminates available drug classes as treatment ...
Cowen Leah E   +4 more
openaire   +3 more sources

Ellagic acid: an alternative for antifungal drugs resistance in HIV/AIDS patients with oropharyngeal candidiasis

open access: yesHIV & AIDS Review. International Journal of HIV-Related Problems, 2020
Oropharyngeal candidiasis (OPC) is considered the most common fungal infection in human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) patients. Antifungal drug, azole group, is the preferred treatment.
Satutya Wicaksono   +4 more
doaj   +1 more source

Examining Signatures of Natural Selection in Antifungal Resistance Genes Across Aspergillus Fungi

open access: yesFrontiers in Fungal Biology, 2021
Certain Aspergillus fungi cause aspergillosis, a set of diseases that typically affect immunocompromised individuals. Most cases of aspergillosis are caused by Aspergillus fumigatus, which infects millions of people annually.
Renato Augusto Corrêa dos Santos   +7 more
doaj   +1 more source

Antifungal drug resistance: an update [PDF]

open access: yesEuropean Journal of Hospital Pharmacy, 2022
The number of antifungal classes is small, and resistance is becoming a much more frequent problem. Much greater emphasis needs to be placed on susceptibility testing and antifungal stewardship. Such efforts demonstrably improve survival and overall clinical outcomes.
openaire   +3 more sources

Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance

open access: yesClinical Chemistry, 2021
Background Infections caused by fungi can be important causes of morbidity and mortality in certain patient populations, including those who are highly immunocompromised or critically ill.
N. Wiederhold
semanticscholar   +1 more source

Surveillance of Antifungal Resistance in Candidemia Fails to Inform Antifungal Stewardship in European Countries

open access: yesJournal of Fungi, 2022
Background: The increasing burden of candidemia and the emergence of resistance, especially among non-Candida albicans strains, represent a new threat for public health.
Liliana Galia   +6 more
semanticscholar   +1 more source

Update on Antifungal Drug Resistance [PDF]

open access: yesCurrent Clinical Microbiology Reports, 2015
Invasive fungal infections remain a major source of global morbidity and mortality, especially among patients with underlying immune suppression. Successful patient management requires antifungal therapy. Yet, treatment choices are restricted due to limited classes of antifungal agents and the emergence of antifungal drug resistance.
Erika Shor, Yanan Zhao, David S. Perlin
openaire   +3 more sources

Home - About - Disclaimer - Privacy